CymitQuimica logo
CDK

CDK

CDK (Cyclin-Dependent Kinase) inhibitors are compounds that block the activity of CDKs, a group of protein kinases that regulate the cell cycle, transcription, and other cellular processes. CDKs are activated by binding to cyclins, and their activity is crucial for the progression of cells through different phases of the cell cycle. Inhibiting CDKs can halt cell division, leading to cell cycle arrest and apoptosis, particularly in cancer cells where CDKs are often dysregulated. CDK inhibitors are widely used in cancer research and have therapeutic potential in treating various cancers. At CymitQuimica, we provide a comprehensive selection of high-quality CDK inhibitors to support your research in cell cycle control, cancer, and therapeutic development.

Found 525 products of "CDK"

Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
products per page.
  • LDC4297
    Targetmol
    + Info

    LDC4297

    CAS:
    LDC4297 (LDC044297) is a potent and selective CDK7 inhibitor.
    Formula:C23H28N8O
    Purity:98.25%
    Color and Shape:Solid
    Molecular weight:432.52

    Ref: TM-T4051

  • CDK5-IN-3
    Targetmol
    + Info

    CDK5-IN-3

    CAS:
    CDK5-IN-3 is a selective and potent CDK5 inhibitor that inhibits CDK5/p25 and CDK2/CycA, and can be used in the study of cancer.
    Formula:C22H26N4O
    Purity:98.21%
    Color and Shape:Solid
    Molecular weight:362.47

    Ref: TM-T61362

  • Palbociclib-d8
    Targetmol
    + Info

    Palbociclib-d8

    CAS:
    Palbociclib-d8 (PD 0332991 D8) is the deuterated form of Palbociclib. Palbociclib is a CDK inhibitor that inhibits CDK4 and CDK6.
    Formula:C24H21D8N7O2
    Purity:98%
    Color and Shape:Solid
    Molecular weight:455.58

    Ref: TM-T12355

  • NCT02
    Targetmol
    + Info

    NCT02

    CAS:
    NCT02 degrades cyclin K, leading to CCNK and CDK12 degradation, potentially aiding metastatic CRC research.
    Formula:C17H16N2O2S
    Color and Shape:Solid
    Molecular weight:312.39

    Ref: TM-T60030

  • NU6102
    Targetmol
    + Info

    NU6102

    CAS:
    NU6102 is a CDK2 inhibitor with antitumor activity against CDK1/cyclinB, CDK1/CDK2, CDK4, DYRK1A , PDK1, and ROCKII, and it can be used to study rectal cancer.
    Formula:C18H22N6O3S
    Purity:99.76%
    Color and Shape:Solid
    Molecular weight:402.47

    Ref: TM-T28218

  • Palbociclib hydrochloride
    Targetmol
    + Info

    Palbociclib hydrochloride

    CAS:
    Palbociclib hydrochloride is the salt form of Palbociclib, a selective and orally available CDK4 and CDK6 inhibitor for breast and hepatocellular carcinoma.
    Formula:C24H31Cl2N7O2
    Purity:99.89%
    Color and Shape:Solid
    Molecular weight:520.46

    Ref: TM-T63576

  • FMF-04-159-2
    Targetmol
    + Info

    FMF-04-159-2

    CAS:
    FMF-04-159-2 is a potent covalent CDK14 & CDK2 inhibito and is able to reduce α-Syn aggregation in neurons, and inhibits TNBC cancer progression.
    Formula:C28H30Cl3N7O5S
    Purity:96.57%
    Color and Shape:Solid
    Molecular weight:683.01

    Ref: TM-T11309

  • SB1317
    Targetmol
    + Info

    SB1317

    CAS:
    SB1317 (TG02) is a potent inhibitor of cyclin dependant kinases (CDKs), Janus kinase 2 (JAK2), and Fms-like tyrosine kinase-3 (FLT3).
    Formula:C23H24N4O
    Purity:99.86%
    Color and Shape:Solid
    Molecular weight:372.46

    Ref: TM-T2653

  • Ribociclib-d6
    Targetmol
    + Info

    Ribociclib-d6

    CAS:
    Ribociclib-d6 is a deuterated compound of Ribociclib (LEE011) for isotope tracing.Ribociclib is an orally available CDK4/6 inhibitor with antitumor activity.
    Formula:C23H30N8O
    Color and Shape:Solid
    Molecular weight:440.57

    Ref: TM-TMID-0003

  • CDK9-IN-1
    Targetmol
    + Info

    CDK9-IN-1

    CAS:
    CDK9-IN-1 is a selective and potent CDK9 inhibitor with antiviral activity used in the study of PRRSV infections.
    Formula:C26H21N5O4S
    Purity:98.52%
    Color and Shape:Solid
    Molecular weight:499.54

    Ref: TM-T10741

  • (E/Z)-Zotiraciclib hydrochloride
    Targetmol
    + Info

    (E/Z)-Zotiraciclib hydrochloride

    CAS:
    (E/Z)-Zotiraciclib ((E/Z)-TG02) hydrochloride is a potent inhibitor of CDK2, JAK2, and FLT3.
    Formula:C23H25ClN4O
    Color and Shape:Solid
    Molecular weight:408.93

    Ref: TM-T62056

  • GP-82996
    Targetmol
    + Info

    GP-82996

    CAS:
    GP-82996 (CINK4) inhibits CDK4/6; IC50s: 1.5 μM (CDK4/D1), 5.6 μM (CDK6/D1), 25 μM (Cdk5/p35); triggers U2OS cancer cell apoptosis.
    Formula:C27H32N6O
    Purity:99.94%
    Color and Shape:Solid
    Molecular weight:456.58

    Ref: TM-T21720

  • Atuveciclib
    Targetmol
    + Info

    Atuveciclib

    CAS:
    Atuveciclib Racemate is an oral CDK9 inhibitor with a 13 nM IC50, targeting P-TEFb/CDK9 selectively.
    Formula:C18H18FN5O2S
    Purity:98.8%
    Color and Shape:Solid
    Molecular weight:387.43

    Ref: TM-T10464L

  • DRB
    Targetmol
    + Info

    DRB

    CAS:
    <p>DRB is a nucleoside analog that inhibits several carboxyl-terminal domain (CTD) kinases including casein kinase II (IC50 range of 4-10 μM)</p>
    Formula:C12H12Cl2N2O4
    Purity:99.46% - 99.83%
    Color and Shape:White To Off-White Crystalline Solid
    Molecular weight:319.14

    Ref: TM-T7789

  • Cdk5 Substrate acetate
    Targetmol
    + Info

    Cdk5 Substrate acetate

    <p>Cdk5, a serine/threonine kinase active in neurons, phosphorylates proteins like histone H1; its synthetic substrate has a Km of 5 µM.</p>
    Formula:C55H103N15O14
    Purity:96.21%
    Color and Shape:Solid
    Molecular weight:1198.5

    Ref: TM-T37207L

  • PF-06873600
    Targetmol
    + Info

    PF-06873600

    CAS:
    PF-06873600: oral CDK inhibitor (CDK2/4/6), Ki 0.09-0.16 nM, potential anticancer drug.
    Formula:C20H27F2N5O4S
    Purity:98.77% - 99.55%
    Color and Shape:Solid
    Molecular weight:471.52

    Ref: TM-T8463

  • AMG 925 HCl
    Targetmol
    + Info

    AMG 925 HCl

    CAS:
    AMG 925 HCl is a selective and potent dual inhibitor of FLT3 (IC50: 2±1 nM) and CDK4 (IC50: 3±1 nM).
    Formula:C26H30ClN7O2
    Color and Shape:Solid
    Molecular weight:508.02

    Ref: TM-T63487

  • CKI-7
    Targetmol
    + Info

    CKI-7

    CAS:
    CKI-7 is a potent and ATP-competitive inhibitor of casein kinase 1 (CK1; IC50: 6 μM; Ki: 8.5 μM) and a selective Cdc7 kinase inhibitor.
    Formula:C11H14Cl3N3O2S
    Purity:>99.99%
    Color and Shape:Solid
    Molecular weight:358.67

    Ref: TM-T19913

  • Palbociclib
    Targetmol
    + Info

    Palbociclib

    CAS:
    Palbociclib is an oral CDK4/6 inhibitor, halts Rb phosphorylation, arrests cell cycle, and curbs tumor growth.
    Formula:C24H29N7O2
    Purity:98% - 99.9%
    Color and Shape:Solid
    Molecular weight:447.53

    Ref: TM-T1785

  • CDK9-IN-30
    Targetmol
    + Info

    CDK9-IN-30

    CAS:
    CDK9-IN-30 is one of the Tat peptide derivatives and inhibits HIV-1 long terminal repeat-activated transcription.
    Formula:C16H20FNO3
    Purity:99.75%
    Color and Shape:Solid
    Molecular weight:293.33

    Ref: TM-T9632